We have a cancer vaccine--why don't we use it?
作者信息
Hall A
出版信息
Trop Med Int Health. 1998 May;3(5):337-8. doi: 10.1046/j.1365-3156.1998.00251.x.
Abstract
摘要
相似文献
1
We have a cancer vaccine--why don't we use it?
Trop Med Int Health. 1998 May;3(5):337-8. doi: 10.1046/j.1365-3156.1998.00251.x.
2
Vaccines: taking a shot at protection.
Nature. 2014 Dec 4;516(7529):S12-3. doi: 10.1038/516S12a.
3
Prevention of mortality from hepatitis B and hepatitis C.
Lancet. 2006 Sep 9;368(9539):896-7. doi: 10.1016/S0140-6736(06)69347-1.
4
[Vaccination against hepatitis B virus].
Presse Med. 2006 Feb;35(2 Pt 2):347-52. doi: 10.1016/s0755-4982(06)74580-8.
5
Hepatitis B virus vaccine for patients with hepatitis C virus infection.
Infection. 2000 Nov-Dec;28(6):341-5. doi: 10.1007/s150100070002.
6
Report of the OAU/STRC Ad Hoc Committee on Hepatitis B Vaccination in Africa.
IARC Sci Publ. 1984(63):393-401.
7
Global control of primary hepatocellular carcinoma with hepatitis B vaccine: the contributions of research in Taiwan.
Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):2-3.
8
The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma.
Res Virol. 1997 Mar-Apr;148(2):91-4. doi: 10.1016/s0923-2516(97)89890-1.
9
From hepatitis to hepatoma: lessons from type B viral hepatitis.
Science. 1993 Oct 15;262(5132):369-70. doi: 10.1126/science.8211155.
10
Towards the elimination of hepatitis B and hepatocellular carcinoma.
S Afr Med J. 2018 Aug 8;108(8b):13-16. doi: 10.7196/SAMJ.2018.v108i8b.13496.
Zotero 插件